MarketPeel
Insider Trading Intelligence
Pricing
…
YC

Yuval Cohen

CRBP
CHIEF EXECUTIVE OFFICER · CORBUS PHARMACEUTICALS HOLDINGS, INC. · CIK 0001626003
FILING MIX · LIFETIME53%/47%
BUYS
25
SELLS
22
TOTAL VALUE
$4.77M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
174,316
AVG SELL PX
$30.44
TRADE KIND
SHOWING 47 / 47
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Yuval Cohen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+64.71%-4.54%-0.10%-4.44%-1.11%—
14d17+47.06%+0.41%+0.56%-0.15%+9.17%—
30d17+35.29%+9.07%+0.92%+8.15%+14.49%—
60d17+35.29%+3.20%-0.08%+3.28%+13.04%—
90d17+29.41%+13.36%+3.67%+9.69%+18.66%—
180d17(1 pending)+68.75%-47.80%+9.53%-57.32%-77.03%—
1y17(3 pending)+71.43%-57.30%+13.90%-71.20%-91.34%—
2y17(4 pending)+84.62%+38.53%+36.46%+2.07%-117.10%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRBP · 174,316 shares · as of Feb 13, 2026
0487,387974,7731,462,1601,949,546202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 25 buys / 22 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
13,871$7.78$108.0K174,316Feb 13, 2026Feb 18, 2026 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
50,000——188,187Jan 14, 2026Jan 16, 2026 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Jan 14, 2026Jan 16, 2026 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
8,973$17.14$153.8K138,187Oct 27, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
8,973$4.26$38.2K147,160Oct 27, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
8,973——22,106Oct 27, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
18,660$4.26$79.5K156,847Oct 24, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
18,660——31,079Oct 24, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
18,660$17.01$317.4K138,187Oct 24, 2025Oct 27, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
7,134$8.76$62.5K138,187Feb 14, 2025Feb 18, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
228,800——228,800Jan 31, 2025Feb 4, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
68,100——145,321Jan 31, 2025Feb 4, 2025 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
1,770$14.10$25.0K86,170Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
11,667——0Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
2,322$42.24$98.1K84,400Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
7,179$42.24$303.2K77,221Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
2,322$4.26$9.9K86,722Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
2,322——49,739Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
1,770——31,057Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
11,667$42.24$492.8K84,400Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
11,667$30.00$350.0K96,067Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
1,770$42.24$74.8K84,400Jun 18, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
9,333——11,667Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
1,770——52,061Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
9,333$46.02$429.5K84,400Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
1,770$46.02$81.5K84,400Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
9,333$30.00$280.0K93,733Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
1,770$4.26$7.5K86,170Jun 17, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
12,487$4.26$53.2K96,887Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
16,830——32,827Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
12,487——53,831Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
16,830$50.17$844.3K84,400Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
16,830$14.10$237.3K101,230Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
12,487$50.17$626.4K84,400Jun 14, 2024Jun 18, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
73,947——73,947Feb 12, 2024Feb 14, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
73,947——84,400Feb 12, 2024Feb 14, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
7,179$4.97$35.7K7,179Jan 26, 2024Jan 30, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE
Chief Executive Officer
7,179$4.97$35.7K0Jan 26, 2024Jan 30, 2024 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,989,546——1,949,546Feb 13, 2023Feb 15, 2023 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
3,800$0.26$1.0K98,230Aug 10, 2022Aug 11, 2022 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
10,500$0.25$2.6K94,430May 16, 2022May 16, 2022 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
8,600$0.37$3.2K83,930Mar 9, 2022Mar 9, 2022 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
1,489,700——1,489,700Feb 1, 2022Feb 2, 2022 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
956,500——956,500Feb 2, 2021Feb 4, 2021 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
4,240$1.21$5.1K75,330Nov 11, 2020Nov 12, 2020 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASE
Chief Executive Officer
4,300$3.49$15.0K71,090Mar 17, 2020Mar 17, 2020 ↗View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
639,000——639,000Mar 6, 2020Mar 9, 2020 ↗View →
Other insiders · CRBP
Loading peer insiders…
About this filer
CIK 0001626003
ROLE
Chief Executive Officer
PRIMARY
CRBP
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001626003DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback